In Regard to Frankart et al
Int J Radiat Oncol Biol Phys
.
2021 Oct 1;111(2):582-584.
doi: 10.1016/j.ijrobp.2021.06.005.
Authors
Pierre-Antoine Laurent
1
,
Kanta Ka
2
,
Bertrand Gachot
3
,
Quitterie de Kerangal
4
,
Pierre Descols
5
,
Jean-Jacques Brau
5
,
Pierre Blanchard
2
,
Nadia Benmoussa
6
Affiliations
1
Department of Radiation Oncology and INSERM U1030 Molecular Radiotherapy, Gustave Roussy Cancer Campus, Villejuif, France.
2
Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
3
Department of Infectious Diseases, Gustave Roussy Cancer Campus, Villejuif, France.
4
Department of Surgery, Division of Maxillofacial Surgery, Gustave Roussy Cancer Campus, Villejuif, France.
5
Department of Surgery, Division of Dentistry, Gustave Roussy Cancer Campus, Villejuif, France.
6
Department of Head and Neck Surgery, Gustave Roussy Cancer Campus, Villejuif, France.
PMID:
34473983
DOI:
10.1016/j.ijrobp.2021.06.005
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Radiotherapy Dosage*